What Is the Worst-Case Scenario in a DEA Pharmacy Audit?
When the DEA Audits a Pharmacy, it has One Goal in Mind: To Uncover Any Statutory or Regulatory Violations So that They Can Be Penalized Appropriately. When agents from the U.S. Drug Enforcement Administration (DEA) show up at your pharmacy and start asking questions, what is at risk? Is it...
Read moreRisk Management in the Midst of the Coronavirus Outbreak: What Do Companies Need to Know?
As the novel coronavirus (COVID-19) continues to spread, the domestic and international risks for U.S. companies continue to grow. So, what do you need to know in order to minimize the immediate and long-term effects on your company’s bottom line? As of March 1, 2020, there have been two confirmed...
Read moreMedical Billing Fraud Allegations Related to Sleep Apnea Implant Therapy
It has been more than 15 years since the U.S. Food and Drug Administration (FDA) first approved implant therapy as an alternative to continuous positive air pressure (CPAP) machines for the treatment of sleep apnea. Over the past decade and a half, this implant therapy, or implantable treatment, for sleep...
Read moreWhat are the Penalties for Healthcare Fraud Under Federal Law?
Healthcare fraud is a federal offense that carries substantial civil and criminal penalties. Doctors, business owners, and others accused of healthcare fraud must engage experienced federal defense counsel in order to avoid practice-threatening consequences. Today, all healthcare providers are at risk for being targeted in federal investigations. Many non-providers are...
Read moreDOJ and VA-OIG Announce New Veterans Affairs Healthcare Fraud Task Force
On October 1, 2019, the U.S. Department of Justice (DOJ) Office of Public Affairs announced that the DOJ and the Department of Veterans Affairs Office of Inspector General (VA-OIG) have established a new joint task force that will focus specifically on targeting VA healthcare fraud. It is known as the...
Read morePreparing for a DEA or State Board Pharmacy Investigation
The DEA and state pharmacy boards can conduct unannounced investigations to confirm compliance. Are you prepared to avoid penalties if federal agents or state auditors show up at your door? Pharmacies in the United States are subject to heavy regulation and strict oversight at the state and federal levels. In...
Read moreHow CGX Laboratories Can Be Compliant
Medicare began providing coverage for genetic cancer screening (CGX) in 2018. While this was a positive development for testing laboratories, some labs that have been billing Medicare for CGX have run into compliance issues. If your testing laboratory bills Medicare for CGX, this article provides an overview of what you...
Read moreCBD Compliance for Pharmacists
More patients are coming to you every day asking about CBD oil and other cannabis-based treatments and medications. Here’s what you need to know in order to maintain federal compliance. When the federal Agriculture Improvement Act of 2018 (commonly known as the “Farm Bill”) was passed late last year, hemp...
Read moreAlzheimer’s Testing Compliance
According to the National Institutes of Health (NIH), it is estimated that more than 5.5 million Americans may suffer from Alzheimer’s disease. Among other things, this means that diagnosing and treating seniors with Alzheimer’s disease presents a significant opportunity for neurologists, psychiatrists, geriatricians, and other healthcare providers to help people...
Read moreHealthcare Fraud Involving Home Sleep Studies: What Do California Doctors and Service Providers Need to Know?
A recent trend in healthcare fraud enforcement involves private insurers and the federal government targeting doctors who recommend patients for home sleep studies (HSS) and HSS service providers. Currently, the insurance companies and federal agencies including the U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human...
Read more